Literature DB >> 868859

The sudden infant death syndrome among Alaskan natives.

J K Fleshman, D R Peterson.   

Abstract

Among Alaskian natives the sudden infant death syndrome (SIDS) occurs at a rate somewhat less than that reported for native Americans indigenous to temperate latitudes. Cases occurred in both the arctic and subarctic regions of the state and among all but one of the ethnically distinct native population groups. No striking male predisposition was evident. These findings are, in general, similar to previously reported accounts from the states of California and Washington. Any theory of SIDS epidemiogenesis must take into account its wide geoethnic and peculiar sex distribution.

Entities:  

Mesh:

Year:  1977        PMID: 868859     DOI: 10.1093/oxfordjournals.aje.a112419

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  5 in total

1.  Impaired fasting tolerance among Alaska native children with a common carnitine palmitoyltransferase 1A sequence variant.

Authors:  Melanie B Gillingham; Matthew Hirschfeld; Sarah Lowe; Dietrich Matern; James Shoemaker; William E Lambert; David M Koeller
Journal:  Mol Genet Metab       Date:  2011-06-28       Impact factor: 4.797

2.  What kind of cot death?

Authors: 
Journal:  Br Med J       Date:  1978-03-18

3.  Birthweight-specific infant mortality for native Americans compared with whites, six states, 1980.

Authors:  M J Vanlandingham; J W Buehler; C J Hogue; L T Strauss
Journal:  Am J Public Health       Date:  1988-05       Impact factor: 9.308

4.  High incidence of sudden infant death syndrome among northern Indians and Alaska natives compared with southwestern Indians: possible role of smoking.

Authors:  M Bulterys
Journal:  J Community Health       Date:  1990-06

5.  Infant mortality reviews in the Aberdeen Area of the Indian Health Service: strategies and outcomes.

Authors:  Mary Lynn EagleStaff; Marilyn G Klug; Larry Burd
Journal:  Public Health Rep       Date:  2006 Mar-Apr       Impact factor: 2.792

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.